Research progress of erythropoietin in the treatment of diabetic retinopathy

Diabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO...

Full description

Bibliographic Details
Main Authors: Dan-Dan Liu, Guo-Tong Xu, Jing-Fa Zhang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2021-09-01
Series:Guoji Yanke Zazhi
Subjects:
Online Access:http://ies.ijo.cn/cn_publish/2021/9/202109009.pdf
_version_ 1818694090611490816
author Dan-Dan Liu
Guo-Tong Xu
Jing-Fa Zhang
author_facet Dan-Dan Liu
Guo-Tong Xu
Jing-Fa Zhang
author_sort Dan-Dan Liu
collection DOAJ
description Diabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO), a glycoprotein hormone, plays a pivotal role in neuroprotection, neurotrophy, anti-inflammation, anti-apoptosis and anti-oxidation etc., in various central nervous system diseases. This review discussed the protective effect of EPO in DR so as to provide new options for DR treatment.
first_indexed 2024-12-17T13:24:03Z
format Article
id doaj.art-05f7acd33ad6453e93983355ae33cf58
institution Directory Open Access Journal
issn 1672-5123
language English
last_indexed 2024-12-17T13:24:03Z
publishDate 2021-09-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series Guoji Yanke Zazhi
spelling doaj.art-05f7acd33ad6453e93983355ae33cf582022-12-21T21:46:46ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51232021-09-012191539154210.3980/j.issn.1672-5123.2021.9.09202109009Research progress of erythropoietin in the treatment of diabetic retinopathyDan-Dan Liu0Guo-Tong Xu1Jing-Fa Zhang2Tongji University School of Medicine;Tongji Eye Institute, Shanghai 200092, ChinaTongji University School of Medicine;Tongji Eye Institute, Shanghai 200092, ChinaDepartment of Ophthalmology, Shanghai General Hospital;Shanghai First People's Hospital, Shanghai 200080, ChinaDiabetic retinopathy(DR)is the most common complication of diabetes mellitus and remains the leading cause of blindness in working-age population. DR affects almost all the retinal cells, leading to the disruption and dysfunction of neurovascular unit and the neural-glial network. Erythropoietin(EPO), a glycoprotein hormone, plays a pivotal role in neuroprotection, neurotrophy, anti-inflammation, anti-apoptosis and anti-oxidation etc., in various central nervous system diseases. This review discussed the protective effect of EPO in DR so as to provide new options for DR treatment.http://ies.ijo.cn/cn_publish/2021/9/202109009.pdfdiabetic retinopathyerythropoietinneurovascular unitneural-glial network
spellingShingle Dan-Dan Liu
Guo-Tong Xu
Jing-Fa Zhang
Research progress of erythropoietin in the treatment of diabetic retinopathy
Guoji Yanke Zazhi
diabetic retinopathy
erythropoietin
neurovascular unit
neural-glial network
title Research progress of erythropoietin in the treatment of diabetic retinopathy
title_full Research progress of erythropoietin in the treatment of diabetic retinopathy
title_fullStr Research progress of erythropoietin in the treatment of diabetic retinopathy
title_full_unstemmed Research progress of erythropoietin in the treatment of diabetic retinopathy
title_short Research progress of erythropoietin in the treatment of diabetic retinopathy
title_sort research progress of erythropoietin in the treatment of diabetic retinopathy
topic diabetic retinopathy
erythropoietin
neurovascular unit
neural-glial network
url http://ies.ijo.cn/cn_publish/2021/9/202109009.pdf
work_keys_str_mv AT dandanliu researchprogressoferythropoietininthetreatmentofdiabeticretinopathy
AT guotongxu researchprogressoferythropoietininthetreatmentofdiabeticretinopathy
AT jingfazhang researchprogressoferythropoietininthetreatmentofdiabeticretinopathy